A randomized trial of induction doses of interferon alone or in combination with ribavirin or ribavirin plus amantadine for treatment of nonresponder patients with chronic hepatitis C

Author： Gramenzi Annagiulia   Andreone Pietro   Cursaro Carmela   Verucchi Gabriella   Boccia Sergio   Giacomoni Pier Luigi   Galli Silvia   Furlini Giuliano   Biselli Maurizio   Lorenzini Stefania   Attard Luciano   Bonvicini Fiorenza   Bernardi Mauro  

Publisher： Springer Publishing Company

ISSN： 0944-1174

Source： Journal of Gastroenterology, Vol.42, Iss.5, 2007-05, pp. : 362-367

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Early decline of hemoglobin correlates with progression of ribavirin-induced hemolytic anemia during interferon plus ribavirin combination therapy in patients with chronic hepatitis C

By Oze Tsugiko   Hiramatsu Naoki   Kurashige Nao   Tsuda Natsuko   Yakushijin Takayuki   Kanto Tatsuya   Takehara Tetsuo   Kasahara Akinori   Kato Michio   Yoshihara Harumasa   Katayama Kazuhiro   Kubota Shinji   Hijioka Taizo   Ishibashi Kazunobu   Oshita Masahide   Hagiwara Hideki   Haruna Yoshimichi   Mita Eiji   Tamura Shinji   Hayashi Norio  

Journal of Gastroenterology, Vol. 41, Iss. 9, 2006-09 ,pp. : 862-872

Springer Publishing Company

Access to resources Recommend Favorite

Viral Kinetics and Treatment Response in Patients with Hepatitis C During Induction and Standard Interferon Therapy in Combination with Ribavirin

By Carlsson T.   Weiland O.   Reichard O.  

Scandinavian Journal of Gastroenterology, Vol. 37, Iss. 10, 2002-10 ,pp. : 1228-1234

Informa Healthcare

Access to resources Recommend Favorite

Pegylated Interferon α-2b, Ribavirin and Amantadine for Chronic Hepatitis C

By Younossi Zobair   McCullough Arthur   Barnes David   Post Anthony   Ong Janus   O’shea Robert   Martin Lisa   Bringman Diane   Farmer Denise   Levinthal Gavin   Mullen Kevin   Carey William   Tavill Anthony   Ferguson Roy   Gramlich Terry  

Digestive Diseases and Sciences, Vol. 50, Iss. 5, 2005-05 ,pp. : 970-975

Springer Publishing Company

Access to resources Recommend Favorite

How to avoid discontinuation of ribavirin in combination with interferon to maintain efficacy of treatment for chronic hepatitis C patients

By Kasahara Akinori  

Journal of Gastroenterology, Vol. 39, Iss. 11, 2004-11 ,pp. : 1125-1126

Springer Publishing Company

Access to resources Recommend Favorite

Interferon-Alpha in Combination with Ribavirin for the Treatment of Chronic Hepatitis C in Patients with Persistently Normal Aminotransferase Levels

By  

Digestion, Vol. 65, Iss. 2, 2002-05 ,pp. : 127-130

Karger

Access to resources Recommend Favorite